首页> 中文期刊>中国医药导刊 >丹红注射液治疗冠心病不稳定型心绞痛临床观察分析

丹红注射液治疗冠心病不稳定型心绞痛临床观察分析

     

摘要

[ABSTRACT]Objective:To investigate the Danhong injection in treatment of coronary heart disease (CHD) in unstable angina pectoris (UA) clinical effect. Methods:86 cases of CHD UA in 2012 January to 2014 January were selected in our hospital as the research object, according to the stochastic averaging principle of distribution will be divided into two groups, each of 43 cases, the control group with conventional therapy treatment, the observation group on the basis of application of Danhong Injection by intravenous infusion. After the comparison of the two patients and the clinical effect and ECG treatment effect. Results:Two groups of patients with clinical symptoms curative effect, total effective rate of observation group was 95.3%, 81.4%in the control group, the difference has statistical signiifcance (P<0.05);the curative effects of the patients with ECG were compared between the two groups, the observation group, the total effective rate was 83.7%, 65.1%in the control group, the difference has statistical signiifcance (P<0.05). Conclusions:The clinical effect of Danhong injection in the treatment of CHD UA is better, can signiifcantly improve the clinical symptoms, electrocardiogram, safe and effective.%目的:探讨丹红注射液治疗冠心病(CHD)不稳定型心绞痛(UA)临床效果。方法:选取2012年1月至2014年1月我院收治的86例CHD UA患者为研究对象,依循随机平均分配原则将其分为两组,各43例,对照组采用常规治疗法予以治疗,观察组于此基础之上应用丹红注射液以静脉输注。比较两者患者治疗之后其临床治疗效果和心电图治疗效果。结果:两组患者临床症状疗效,观察组总有效率为95.3%,对照组为81.4%,差异比较具统计学意义(P<0.05);两组患者心电图疗效,观察组总有效率为83.7%,对照组为65.1%,差异比较具统计学意义(P<0.05)。结论:丹红注射液治疗CHD UA临床效果较佳,可明显改善临床症状、心电图,安全有效。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号